The Minute Affect in Cost for Canadian Prescription Drug Imports in the American Healthcare System
This paper will seek to discuss the minimal affect that Canadian imports will have on the cost of American health care costs for drugs. In this manner, we can reveal how the far smaller market in Canada cannot meet the massive demand currently in America, and that the F.D.A. is overreacting when they claim that Canadian drugs are of poor quality. We can see that Americans will, in the long run, pay the same since the Canadians too will raise their prices if more Americans buy their products.